Wet AMD needs fast treatment: NICE recommends starting anti-VEGF injections within 2 weeks of diagnosis, because untreated wet AMD can cause permanent central vision loss within weeks. In 2026, NHS first-injection waits range from about 1–4 weeks in the best-resourced regions to 6–12 weeks in the most stretched, and repeat maintenance injections are frequently delayed beyond their due date. If you have sudden distortion or a new blur in your central vision, seek same-week assessment. Private anti-VEGF is available within days, from £900 per injection.
Fast answer: how long is the NHS wait for wet AMD injections?
Wet AMD affects around 40,000 new people in the UK each year and is the commonest cause of rapid, severe central vision loss in older adults. Anti-VEGF injections (into the eye) stop the abnormal leaking blood vessels — but only if given promptly and then maintained. NICE guidance sets a 2-week target from diagnosis to first injection. In 2026 most NHS macular units hit that for new patients, but the sheer volume of ongoing injections — among the highest-volume activities in the whole NHS — means maintenance appointments are where delays bite.
Honest one-liner: for wet AMD, speed is everything and the drugs are the same on the NHS and privately. The reason some patients pay is to start within days, or to keep their maintenance injections exactly on schedule when the NHS clinic is running late — not because private drugs work better.
Region-by-region NHS wet AMD first-injection waits (2026 indicative)
Indicative NHS waits from wet-AMD referral to first anti-VEGF injection by UK region in 2026. These are the rapid-access ‘fast-track macular’ pathways; local variation is wide.
NICE says treatment should start within 2 weeks of diagnosis, because untreated wet AMD can cause rapid, permanent central vision loss. Many regions exceed that target — and repeat maintenance injections, where sight is also at risk, are a separate pressure.
| Region / nation | Typical referral-to-first-injection wait (2026) | Notes |
|---|---|---|
| London & South East (England) | 1–4 weeks | Dedicated macular treatment centres; rapid-access clinics |
| North West (England) | 2–5 weeks | High-volume macular services in Manchester & Liverpool |
| South West (England) | 2–6 weeks | Bristol, Plymouth, Exeter macular units |
| Midlands (England) | 2–6 weeks | Birmingham & Nottingham; maintenance-injection capacity pressure |
| North East & Yorkshire (England) | 2–6 weeks | Newcastle, Leeds, Sheffield macular clinics |
| Scotland (urban boards) | 2–6 weeks | Rapid-access macular pathways in the central belt |
| East of England | 3–7 weeks | Norfolk & Suffolk historically stretched |
| Wales (Cardiff / South East) | 3–8 weeks | Cardiff & Vale, Aneurin Bevan macular services |
| Scotland (Highland / islands / rural) | 3–9 weeks | Geography limits rapid access |
| Wales (West / North) | 4–10 weeks | Hywel Dda & Betsi Cadwaladr historically longest |
| Northern Ireland | 4–12 weeks | Longest UK waits; macular capacity under sustained pressure |
These are indicative typical ranges; your local macular service may be faster or slower. The bigger risk for most patients is the maintenance backlog, next.
The maintenance-injection backlog — the delay that quietly costs vision
Wet AMD is not treated once. After the initial ‘loading’ injections, most patients need ongoing injections every 4 to 12 weeks, indefinitely, to keep the disease inactive. Because these repeat injections are not counted in the 18-week Referral-to-Treatment target, they are vulnerable when clinics are full — and a delayed maintenance injection can allow a bleed that permanently reduces central vision.
- Why it matters — each delayed injection is a window in which the abnormal vessels can leak or bleed; lost central vision does not come back.
- Volume pressure — intravitreal injections are one of the highest-volume procedures in the NHS, so even efficient units run tight.
- What you can do — if your next injection is overdue, or you notice new distortion on an Amsler grid, contact your macular clinic and ask to be seen; do not simply wait.
Injection overdue or treatment delayed? A private retinal assessment with OCT is available within days, and anti-VEGF injections can be given on a reliable schedule from £900.
Book an assessmentThe 2-week wet-AMD pathway explained
Wet AMD sits on a fast-track pathway rather than the ordinary routine list. Your optometrist or GP should make an urgent referral the same day they suspect wet AMD; the macular service should assess with OCT imaging and, if confirmed, give the first injection within about 2 weeks.
- Suspected wet AMD — sudden distortion (straight lines look bent), a new central blur or dark patch — is an urgent, not routine, referral.
- First injection should follow within roughly 2 weeks of diagnosis under NICE guidance.
- Maintenance injections are scheduled by your consultant (a ‘treat-and-extend’ interval); these are not covered by the 18-week target.
Urgent warning signs — when to seek same-week assessment
See an optometrist or eye service urgently, and ask for a wet-AMD assessment, if you notice:
- Straight lines (door frames, tiles) suddenly looking bent or wavy.
- A new blurred or dark patch in the centre of your vision.
- Colours looking washed out, or letters dropping out when you read.
- These changes in one eye — cover each eye in turn to check.
An Amsler grid at home helps you monitor. New distortion is the classic warning of a wet-AMD conversion and should be checked within days, not weeks.
The anti-VEGF injections used for wet AMD
All the licensed agents are available on the NHS and privately; the choice depends on your consultant’s assessment:
- Aflibercept (Eylea, and Eylea HD 8mg) — a mainstay, with longer intervals possible on the 8mg form.
- Faricimab (Vabysmo) — a newer dual-action agent that can extend intervals for suitable patients.
- Ranibizumab (Lucentis) and its biosimilars (for example Byooviz, Ongavia) — widely used and lower cost.
- Aflibercept biosimilars (for example Yesafili) — newer, lower-cost options.
- Bevacizumab (Avastin) — used off-label in some settings.
See our guide to wet AMD vs dry AMD treatment and macular degeneration treatment.
How to check or escalate your wet-AMD wait
- Contact the macular clinic directly (details on your appointment letter) and ask when your next injection is due and whether it is booked to that date.
- Report new symptoms — sudden distortion or central blur — the same day; this can move you up the list.
- PALS — the trust Patient Advice and Liaison Service can help escalate an overdue injection.
- Right to choose (England) — ask your optometrist or GP about faster ICB-contracted macular providers.
UK 2026 private wet AMD / anti-VEGF prices — itemised
If you choose to go private to start quickly or to keep maintenance on schedule, typical UK 2026 self-pay fees are:
| Item | UK 2026 typical fee | Notes |
|---|---|---|
| Consultant retina assessment + OCT | from £340 | Confirms wet AMD and plans treatment |
| Anti-VEGF injection — biosimilar | from £900 | Ranibizumab / aflibercept biosimilar, drug included |
| Anti-VEGF injection — branded (Eylea, Vabysmo) | from £2,700 | Longer-interval agents; drug included |
| First-year course | typically 7–8 injections | Loading doses then a treat-and-extend interval |
| NHS | Free | Same drugs, per the fast-track pathway above |
Prices are an indicative UK CQC-registered sample; always ask for a written all-inclusive quotation. Related guides: macular degeneration cost, private anti-VEGF injections, private retina consultation cost.
Frequently asked questions
Sources and methodology
- Clinical guidance: NICE NG82 (Age-related macular degeneration); NICE technology appraisals for anti-VEGF agents; Royal College of Ophthalmologists retinal and macular guidance.
- Waiting-list data: NHS England Referral-to-Treatment (Ophthalmology); Public Health Scotland, NHS Wales and HSC NI outpatient statistics.
- Editorial review: reviewed by a UK GMC-registered consultant ophthalmic surgeon before publication.
Independent sources we reference: NICE NG82, Royal College of Ophthalmologists and NHS age-related macular degeneration.
Editorial information · NHS waiting times change month to month and this is not a substitute for personalised medical advice. Always check the official up-to-date source for your specific trust or board.